Literature DB >> 27744570

Neuroprotection Induced by Transplanted CDK5 Knockdown Astrocytes in Global Cerebral Ischemic Rats.

Andrea Becerra-Calixto1, Gloria Patricia Cardona-Gómez2.   

Abstract

Cerebral ischemia is a cerebrovascular episode that generates a high incidence of death and physical and mental disabilities worldwide. Excitotoxicity, release of free radicals, and exacerbated immune response cause serious complications in motor and cognitive areas during both short and long time frames post-ischemia. CDK5 is a kinase that is widely involved in the functions of neurons and astrocytes, and its over-activation is implicated in neurodegenerative processes. In this study, we evaluated the brain parenchymal response to the transplantation of CDK5-knockdown astrocytes into the somatosensory cortex after ischemia in rats. Male Wistar rats were subjected to the two-vessel occlusion (2VO) model of global cerebral ischemia and immediately transplanted with shCDK5miR- or shSCRmiR-transduced astrocytes or with untransduced astrocytes (Control). Our findings showed that animals transplanted with shCDK5miR astrocytes recovered motor and neurological performance better than with those transplanted with WT or shSCRmiR astrocytes. Cell transplantation produced an overall prevention of neuronal loss, and CDK5-knockdown astrocytes significantly increased the immunoreactivity (IR) of endogenous GFAP in branches surrounding blood vessels, accompanied by the upregulation of PECAM-1 IR in the walls of vessels in the motor and somatosensory regions and by an increase in Ki67 IR in the subventricular zone (SVZ), partially associated with the production of BDNF. Together, our data suggest that transplantation of shCDK5miR astrocytes protects the neurovascular unit in ischemic rats, allowing the motor and neurological function recovery.

Entities:  

Keywords:  Astrocytes; Brain ischemia; Cell therapy; Motor and somatosensory skills; Transplant

Mesh:

Substances:

Year:  2016        PMID: 27744570     DOI: 10.1007/s12035-016-0162-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  73 in total

1.  CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia.

Authors:  Johana A Gutiérrez-Vargas; Alejandro Múnera; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

2.  Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems.

Authors:  J Frisén; V M Verge; K Fried; M Risling; H Persson; J Trotter; T Hökfelt; D Lindholm
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 3.  Therapeutical Strategies for Spinal Cord Injury and a Promising Autologous Astrocyte-Based Therapy Using Efficient Reprogramming Techniques.

Authors:  Hao Yang; Cui-Cui Liu; Chun-Yu Wang; Qian Zhang; Jiang An; Lingling Zhang; Ding-Jun Hao
Journal:  Mol Neurobiol       Date:  2015-04-12       Impact factor: 5.590

4.  Level of systolic blood pressure within the normal range and risk of recurrent stroke.

Authors:  Bruce Ovbiagele; Hans-Christophe Diener; Salim Yusuf; Reneé H Martin; Daniel Cotton; Richard Vinisko; Geoffrey A Donnan; Philip M Bath
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

5.  The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cells.

Authors:  Eleni Papanikolaou; Maria Georgomanoli; Evangelos Stamateris; Fottes Panetsos; Markisia Karagiorga; Panagiotis Tsaftaridis; Stelios Graphakos; Nicholas P Anagnou
Journal:  Hum Gene Ther       Date:  2011-12-05       Impact factor: 5.695

Review 6.  Targeting astrocytes for stroke therapy.

Authors:  Yanxin Zhao; David A Rempe
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 7.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

Review 8.  Cerebral ischemia, cell cycle elements and Cdk5.

Authors:  Serge Timsit; Bénédicte Menn
Journal:  Biotechnol J       Date:  2007-08       Impact factor: 4.677

9.  Astrocytes as a source for extracellular matrix molecules and cytokines.

Authors:  Stefan Wiese; Michael Karus; Andreas Faissner
Journal:  Front Pharmacol       Date:  2012-06-26       Impact factor: 5.810

Review 10.  Neural stem cells: brain building blocks and beyond.

Authors:  Tobias Bergström; Karin Forsberg-Nilsson
Journal:  Ups J Med Sci       Date:  2012-05       Impact factor: 2.384

View more
  9 in total

1.  Recovery of Neurovascular Unit Integrity by CDK5-KD Astrocyte Transplantation in a Global Cerebral Ischemia Model.

Authors:  Andrea Becerra-Calixto; Rafael Posada-Duque; Gloria Patricia Cardona-Gómez
Journal:  Mol Neurobiol       Date:  2018-03-22       Impact factor: 5.590

Review 2.  Therapeutic Potential of Astrocyte Transplantation.

Authors:  Nataly Hastings; Wei-Li Kuan; Andrew Osborne; Mark R N Kotter
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 3.  Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Authors:  Gloria Patricia Cardona-Gómez; Francisco Lopera
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

Review 4.  The Role of Astrocytes in Neuroprotection after Brain Stroke: Potential in Cell Therapy.

Authors:  Andrea Becerra-Calixto; Gloria P Cardona-Gómez
Journal:  Front Mol Neurosci       Date:  2017-04-03       Impact factor: 5.639

Review 5.  Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells.

Authors:  Lucas Le Roy; Anne Letondor; Cloé Le Roux; Ahmed Amara; Serge Timsit
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

Review 6.  Astrocyte Activation in Neurovascular Damage and Repair Following Ischaemic Stroke.

Authors:  Adjanie Patabendige; Ayesha Singh; Stuart Jenkins; Jon Sen; Ruoli Chen
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

Review 7.  Three decades of Cdk5.

Authors:  Ping-Chieh Pao; Li-Huei Tsai
Journal:  J Biomed Sci       Date:  2021-11-23       Impact factor: 8.410

8.  Modeling Traumatic Brain Injury in Human Cerebral Organoids.

Authors:  Santiago Ramirez; Abhisek Mukherjee; Sofia Sepulveda; Andrea Becerra-Calixto; Nicolas Bravo-Vasquez; Camila Gherardelli; Melissa Chavez; Claudio Soto
Journal:  Cells       Date:  2021-10-07       Impact factor: 6.600

Review 9.  The role of Cdk5 in neurological disorders.

Authors:  Chuncao Ao; Chenchen Li; Jinlun Chen; Jieqiong Tan; Liuwang Zeng
Journal:  Front Cell Neurosci       Date:  2022-07-28       Impact factor: 6.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.